Similar companies
Income Statement (DKK)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 68.1B | 4.1% |
| Gross Profit | 57.8B | 4.2% |
| Cost of Revenue | 10.3B | 3.6% |
| Operating expense | 42.1B | 83% |
| Net Income | 20.1B | 21.1% |
Balance Sheet (DKK)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 369B | 23.6% |
| Total Liabilities | 257B | 28.4% |
| Total Equity | 113B | 13.8% |
| Shares Outstanding | 4.45B | 0.4% |
Cash Flow (DKK)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 50.5B | 252.8% |
| Cash from financing | 16.7B | 163.2% |
Financial Highlights for Novo Nordisk in Q2 '24
Novo Nordisk reported a revenue of 68.1B, which is a 4.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 57.8B, marking a 4.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 10.3B, a 3.6% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 42.1B, showing a 83% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 20.1B, showing a -21.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Novo Nordisk faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
